These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25038507)

  • 1. Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening.
    Ghattas MA; Atatreh N; Bichenkova EV; Bryce RA
    J Mol Graph Model; 2014 Jul; 52():114-23. PubMed ID: 25038507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
    Frimurer TM; Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biophys J; 2003 Apr; 84(4):2273-81. PubMed ID: 12668436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating ligand-based and protein-centric virtual screening of kinase inhibitors using ensembles of multiple protein kinase genes and conformations.
    Dixit A; Verkhivker GM
    J Chem Inf Model; 2012 Oct; 52(10):2501-15. PubMed ID: 22992037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing false positives in kinase virtual screens.
    Perola E
    Proteins; 2006 Aug; 64(2):422-35. PubMed ID: 16708364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
    Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
    J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based virtual screening approach for discovery of covalently bound ligands.
    Toledo Warshaviak D; Golan G; Borrelli KW; Zhu K; Kalid O
    J Chem Inf Model; 2014 Jul; 54(7):1941-50. PubMed ID: 24932913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.
    Stroganov OV; Novikov FN; Stroylov VS; Kulkov V; Chilov GG
    J Chem Inf Model; 2008 Dec; 48(12):2371-85. PubMed ID: 19007114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Shape Similarity in Pose Selection and Virtual Screening in CSARdock2014 Exercise.
    Kumar A; Zhang KY
    J Chem Inf Model; 2016 Jun; 56(6):965-73. PubMed ID: 26247231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
    Brylinski M
    J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B.
    Doman TN; McGovern SL; Witherbee BJ; Kasten TP; Kurumbail R; Stallings WC; Connolly DT; Shoichet BK
    J Med Chem; 2002 May; 45(11):2213-21. PubMed ID: 12014959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand efficiency based approach for efficient virtual screening of compound libraries.
    Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
    Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
    Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple active site corrections for docking and virtual screening.
    Vigers GP; Rizzi JP
    J Med Chem; 2004 Jan; 47(1):80-9. PubMed ID: 14695822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
    Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
    J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
    Hou X; Li K; Yu X; Sun JP; Fang H
    J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.